Article Details

Avacta enters licence agreement with Point Biopharma

Retrieved on: 2021-01-07 08:59:08

Tags for this article:

Click the tags to see associated articles and topics

Avacta enters licence agreement with Point Biopharma. View article details on hiswai:

Excerpt

Cancer therapy and diagnostics developer Avacta Group has entered into a licence agreement with Point Biopharma, it announced on Thursday, ...

Article found on: www.sharecast.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up